1001 genes exhibiting an interquartile range of >2

Additional File 2-Selected gene list corresponding to the cluster analysis shown in Figure 2 and 3. Each gene is accompanied by its measured signal over time (data shows average log2 ratios  normalized with quantile method). Genes with one or more missing

Additional File 3-List of most variable genes among Mouse models with Brca1 deficiency. List of 339 probes that passed intensity and missing-value filters and had Standard Deviation (SD Gene Vector) >= 1.5 (to remove genes that have standard deviations of

Additional File 4-List of most variable genes among original and passaged Brca1 mammary tumors. List of 416 probes that in addition to passing intensity and missing-value filters had a minimum 2.5-fold expression change in either direction from the median

Table 1b. Selected Genes Differentially Expressed in High-Grade Astrocytomas (Genes down-regulated in gliomas)

Table 1a. Selected Genes Differentially Expressed in High-Grade Astrocytomas (Genes up-regulated in gliomas)

TableS3b: F-N^int highest (genes with a >1.75-fold difference in expression between populations F-N^int and F-N^lo  focusing on those in which F-N^int or - N^lo expression was the highest or lowest of the four populations examined)

TableS3d: F-N^lo highest (genes with a >1.75-fold difference in expression between populations F-N^int and F-N^lo  focusing on those in which F-N^int or - N^lo expression was the highest or lowest of the four populations examined)

TableS3c: F-N^lo lowest (genes with a >1.75-fold difference in expression between populations F-N^int and F-N^lo  focusing on those in which F-N^int or - N^lo expression was the highest or lowest of the four populations examined)

TableS3a: F-N^int lowest (genes with a >1.75-fold difference in expression between populations F-N^int and F-N^lo  focusing on those in which F-N^int or - N^lo expression was the highest or lowest of the four populations examined)

Figure 1. 34 probe sets identified differential expression between 17 serous tumors that were obtained from 10 patients showing early disease progression (within 18 months after surgery) and 7 patients who showed no disease progression in the 2 years foll